Az előzetes program a "Kapcsolódó dokumentumok" alatt tekinthető meg.

Budapesten tartja az EUSOBI, az Európai Emlődiagnosztikai Társaság (European Society of Breast Imaging) következő nemzetközi kongresszusát október 3-5-én, 72 országból, 1000 fő részvételével.

Az európai emlő radiológus szakemberek legnagyobb éves szakmai összejövetele Európán kívülről is számos orvost vonz.

A világ vezető intézményeinek legismertebb kutatói itt ismertetik legfrissebb felfedezéseiket. Az emlőrák elleni küzdelemben az orvosszakmai tudományos felfedezések a legfontosabbak.

Forrai Gábor, a helyi szervezőbizottság elnöke és az EUSOBI előző elnöke, hangsúlyozta, hogy a rendezvényen kiemelt témának számít a mesterséges intelligencia és a radiológia szerepe az emlődaganatok gyógyításában, például az intervenciós eljárások, azaz az emlődaganatok nem sebészi kezelései is. A mostani rendezvényen több, a társszakmákból érkező szereplő is részt vesz, mert a team munka rendkívül fontos az emlőrák ellátásában.

A kiállításon és az előadásokon mutatják be az emlődiagnosztika legújabb eszközeit: az új képalkotó eszközöket – mint a digitális tomoszintézises mammográfok legújabb verzióit, az újfajta ultrahang készülékeket, az emlő MRI új fejlesztéseit, valamint a legfejlettebb mintavételi eljárásokat. Az emlőrák elleni küzdelem kiemelt hónapja az október, ami a rendezvénynek különös jelentőséget ad.

Kontakt:
K&M Congress Kft.
tel: 06-1-3012000,
fax: 06-1-3012001
e-mail: katalin.matray@kmcongress.com

Dear colleagues!
 
EANS Pediatric Section announce our next webinar “Syringomyelia at different ages”, devoted to the peculiarities of pathophysiology, diagnostics and treatment of Syringomyelia in different periods of life.
 
 
Moderators:

Federico Di Rocco (Pediatric Section)

Marianne Juhler (CSF Disorders Section/Pediatric Section)

When: 25th May 2023, 17:00 CEST

Where: https://us02web.zoom.us/webinar/register/WN_Zw-0yKisTvCAaPA-U_6Tcw


A program megtekinthető a kapocsolt dokumentum alatt!

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.

Generalised Pustular Psoriasis (GPP) – a serious rare disease and its treatment


Hereby we cordially invite you to the international webinar on Generalized Pustular Psoriasis, which will take place on June 6th from 4:00 p.m. to 5:00 p.m.

Prof. Wolf (Department of Dermatology, Medical University of Graz, Austria) and Prof. Pavlovsky (Department of Dermatology, University of Tel Aviv, Israel) will discuss the characteristics and challenges of this rare disease and concrete treatment experiences, with a focus on first experiences with spesolimab in this indication.

You can find more information about this event and the link to register in the invitation attached.

Registration:
To access the webinar, please use the following link to register for the event: REGISTRATION

After registration, you will receive an exclusive link to access the webinar

Time: Tuesday, 6th of June 2023 | 16:00-17:00 | Central European Summertime (UTC+2)

Agenda:
16:00-16:05 Welcome and Introduction
16:05-16:20 Pathophysiology, diagnosis and treatment of GPP P. Wolf
16:20-16:35 Practical treatment experiences in GPP L. Pavlovsky
16.35-17:00 Discussion

Prof. Peter Wolf, MD
Peter Wolf, MD, is Professor of Dermatology and Chair of the Department of Dermatology at the Medical University Graz, Austria. Dr. Wolf has long-standing clinical and research interests in inflammatory skin diseases including GPP. He is the principal investigator of numerous previous and ongoing clinical trials investigating novel treatment strategies in skin diseases. As an active member of the PhD programme Molecular Medicine (MOLMED) of the Medical University of Graz his translational research group addresses mechanistic issues of dermatological treatments.

Prof. Lev Pavlovsky
Dr. Lev Pavlovsky, a Clinical Associate Professor of Dermatology at Tel Aviv University‘s Medical School in Israel, is the Director of the Psoriasis Treatment Service at Rabin Medical Center. With particular expertise in immunobiological treatments, he has led several international clinical trials and authored numerous scientific publications and book chapters. Dr. Pavlovsky also serves as a Councilor at the International Psoriasis Council and the National Representative in the SPIN network.